Cellcept 250 mg

Cellcept 250 mg is a medicine authorised by Swissmedic under authorisation number 67391. The authorisation holder is APS-Arzneimittel-Parallelimport- Service AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 October 2019 and the authorisation is valid without a time limit. ATC code L04AA06 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 67391
  • ATC L04AA06
  • Synthetic medicines
Authorisation data
Authorisation number67391
NameCellcept 250 mg
Full nameCellcept 250 mg, Kapseln
Authorisation holderAPS-Arzneimittel-Parallelimport- Service AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL04AA06
First authorisation02 October 2019
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Cellcept 250 mg, KapselnB02 October 2019

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1100Kapsel(n)L04AA0607.15.0.B
2300Kapsel(n)L04AA0607.15.0.B
3300Kapsel(n)L04AA0607.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Cellcept 250 mg authorised in Switzerland?

Yes. Cellcept 250 mg is authorised by Swissmedic under authorisation number 67391, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Cellcept 250 mg have?

Cellcept 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Cellcept 250 mg?

The authorisation holder is APS-Arzneimittel-Parallelimport- Service AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com